Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Fusen Pharmaceutical Co., Ltd. ( (HK:1652) ) just unveiled an announcement.
Fusen Pharmaceutical Company Limited has announced a board meeting scheduled for March 28, 2025, to discuss and approve the annual results for the year ending December 31, 2024. The meeting will also consider the potential payment of a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about Fusen Pharmaceutical Co., Ltd.
Fusen Pharmaceutical Co., Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products, serving a diverse market with its range of health-related offerings.
YTD Price Performance: -66.88%
Average Trading Volume: 407,487
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$187.5M
See more insights into 1652 stock on TipRanks’ Stock Analysis page.